Skip to main content
SpringerLink
Log in

Schilddrüsenkarzinome

  • Chapter
Therapiekonzepte Onkologie

  • 67 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Robbins J, Merino MJ, Boice JD Jr, Ron E, Ain KB, Alexander HR, Norton JA, Reynolds J (1991) Thyroid cancer: a lethal endocrine neoplasm. Ann Intern Med 115:133–147

    Article  PubMed  CAS  Google Scholar 

  2. Reiners Chr (1993) Besondere Risikofaktoren der Struma maligna. In: Struma maligna. Derzeitiger Stand in Diagnose und Therapie (Hrsg) Pimpl W, Galvan G, Kogelnik HD et al. Springer-Verlag, Berlin Heidelberg New York: p 12–20

    Chapter  Google Scholar 

  3. Schneider AB (1990) Radiation-induced thyroid tumors. Endocrinol Metab Clin North Am 19:495–508

    PubMed  CAS  Google Scholar 

  4. Schneider AB, Ron E, Lubin J, Stovall M, Gierlowski TC (1993) Dose-response relationships for radiation-induced thyroid cancer and thyroid nodules: evidence for the prolonged effects of radiation on the thyroid. J Clin Endocrinol Metab 77:362–369

    Article  PubMed  CAS  Google Scholar 

  5. Kerber RA, Till JE, Simon SL, Lyon JL, Thomas DC, Preston-Martin S, Rallison ML, Lloyd RD, Stevens W (1993) A cohort study of thyroid disease in relation to fallout from nuclear weapons testing. JAMA 270:2076–2082

    Article  PubMed  CAS  Google Scholar 

  6. Reiners C (1993) Radioiodtherapie. Indikation, Durchführung und Risiken. Dt Ärztebl 90:2996–3003

    Google Scholar 

  7. Franceschi S, Boyle P, Maisonneuve P, La Vecchia C, Burt AD, Kerr DJ, MacFarlane GJ (1993) The Epidemiology of Thyroid Carcinoma. Critical Reviews in Oncogenesis 4:25–52

    PubMed  CAS  Google Scholar 

  8. Schröder S (1993) Histological classification of thyroid tumours: a review. Exp Clin Endocrinol 101:1–6

    Google Scholar 

  9. TNM-Klassifikation maligner Tumoren (1997) (Hrsg) Wittekind Ch, Wagner G, 5. Auflage, Springer-Verlag

    Chapter  Google Scholar 

  10. Schröder S, Dralle H, Rehpenning W, Böcker W (1987) Prognosekriterien des papillären Schilddrüsenkarzinoms. Langenbecks Arch Chir 371:263

    Article  PubMed  Google Scholar 

  11. Hedinger CE (1993) Probleme der Klassifizierung von Schilddrüsentumoren. Ihre Bedeutung für Prognose und Therapie. Schweiz Med Wschr 123:1673–1681

    PubMed  CAS  Google Scholar 

  12. Reiners C, Hüfner M (1987) Nachsorge des papillären, follikulären und onkozytären Schilddrüsenkarzinoms. In: Schilddrüsenmalignome. Diagnostik, Therapie und Nachsorge (Hrsg) Börner W, Reiners Chr; Schattauer-Verlag, Stuttgart: p 159–183

    Google Scholar 

  13. Cooper DS, Schneyer CR (1990) Follicular and Hurthle cell carcinoma of the thyroid. Endocrinol Metab Clin North Am 19:577–591

    PubMed  CAS  Google Scholar 

  14. Wahl RA, Vietmeier P, Hübner K, Simon D (1990) Undifferenzierte C-Zell-Karzinome. In: Diagnostische und operative Strategien bei endokrinen Erkrankungen (eds) Junginger Th, Beyer J, pmi-Verlag, Frankfurt a.M. p 263–289

    Google Scholar 

  15. Matsuzuka F, Miyauchi A, Katayama S, Narabayashi I, Ikeda H, Kuma K, Sugawara M (1993) Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid 3:93–99

    Article  PubMed  CAS  Google Scholar 

  16. Tiemann M, Menke AOH, Parwaresch R (1993) Pathogenesis, morphology and molecular genetics of non-Hodgkin’s lymphomas of the thyroid gland. Exp Clin Endocrinol 101:33–38

    Google Scholar 

  17. Reiners C, Stuschke M (1996) Schilddrüse. In: Strahlentherapie — Radiologische Onkologie (Hrsg) Scherer E, Sack H, Springer Verlag Heidelberg 401–423

    Google Scholar 

  18. Goretzki PE, Witte J, Ohmann C, Stallmann C, Röher HD (1993) On the significance of lymph-node metastases of differentiated thyroid carcinoma on tumor recurrence and patient survival (a quantitative approach by meta-analysis and multivariate analysis of retrospective studies). Exp Clin Endocrinol 101:118–123

    Google Scholar 

  19. Byar DP, Green SB, Dor P, Williams D, Conon J, van Gilse HA, Mayer M, Sylvester RJ, van Glabbeke M (1979) A prognostic index for thyroid carcinoma. A study of the EORTC thyroid cancer cooperative group. Europ J Cancer 15:1033–1041

    CAS  Google Scholar 

  20. Cunningham MP, Duda RB, Recant W, Chmiel JS, Sylvester JA, Fremgen A (1990) Survival discriminants for differentiated thyroid cancer. Am J Surg 160:344–347

    Article  PubMed  CAS  Google Scholar 

  21. Brennan MD, Bergstralh EJ, van Heerden JA, McConahey WM (1991) Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome [see comments]. Mayo Clin Proc 66:11–22

    Article  PubMed  CAS  Google Scholar 

  22. DeGroot LJ, Kaplan EL, McCormick M, Straus FH (1990) Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71: 414–424

    Article  PubMed  CAS  Google Scholar 

  23. Mazzaferri EL, Jhiang SM (1994) Long-term Impact of Initial Surgical and Medical Therapy on Papillary and Follicular Thyroid Cancer. Amer J Med 97:418–428

    Article  PubMed  CAS  Google Scholar 

  24. Samaan NA, Schultz PN, Hickey RC (1988) Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapy. J Clin Endocrinol Metab 67:801–805

    Article  PubMed  CAS  Google Scholar 

  25. Samaan NA, Schultz EN, Hickey RC (1992) Well-differentiated Thyroid Carcinoma and the Results of Various Modalities of Treatment. A retrospective Review of 1599 Patients. J Clin Endocrinol Metab 75:714–720

    Article  PubMed  CAS  Google Scholar 

  26. Thoresen SO, Akslen LA, Glattre E, Haldorsen T, Lund EV, Schoultz M (1989) Survival and prognostic factors in differentiated thyroid cancer — a multivariate analysis of 1055 cases. Br J Cancer 59:231–235

    Article  PubMed  CAS  Google Scholar 

  27. Shah JP, Loree TR, Dharker D, Strong EW, Begg C, Vlamis V (1992) Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 164:658–661

    Article  PubMed  CAS  Google Scholar 

  28. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS (1994) Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050–1057

    Google Scholar 

  29. Reiners C (1992) Nuklearmedizinische Diagnostik des hypofunktionellen Strumaknotens. Nuklearmediziner 15:15–23

    Google Scholar 

  30. Reinwein D, Benker G, Windeck R, Eigler FW, Leder LD, Mlynek ML, Creutzig H, Reiners C (1989) Erstsymptome bei Schilddrüsenmalignomen: Einfluß von Alter und Geschlecht in einem Iodmangelgebiet. Erfahrungen an 1116 Patienten. Dtsch Med Wochenschr 114:775–782

    Article  PubMed  CAS  Google Scholar 

  31. Rüschoff J, Hofstädter F (1997) Wertigkeit der Schilddrüsenpunktionszytologie zur Selektion verdächtiger Knoten. Onkologe 3:16–21

    Article  Google Scholar 

  32. Dralle H (1993) Metaanalyis of thyroid cancer risk in patients with cold thyroid nodules and multinodular goiter. Exp Clin Endocrinol 101:109–117

    Google Scholar 

  33. Arnholdt H (1993) Intraoperative frozen section examination of thyroid tumours. Exp Clin Endocrinol 101:7–10

    Article  Google Scholar 

  34. Hüfner M, Reiners C (1987) Thyroglobulin and Thyroglobulin Antibodies in the Follow-up of Thyroid Cancer and Endemic Goiter. Thieme Verlag Stuttgart — New York

    Google Scholar 

  35. Reiners C. Schilddrüsenkarzinom. In: Lüthgens M, Schlegel G (Hrsg) Tumormarkersystem CEA-TPA. TumorDiagnostik Verlag Leonberg, p 175, 191

    Google Scholar 

  36. Frilling A (1997) Genetisches Screening in Familien mit multipler endokriner Neoplasie Typ 2. Onkologe 3:38–42

    Article  Google Scholar 

  37. Deutsche Gesellschaft für Chirurgie (1996) Leitlinien der Therapie maligner Schilddrüsentumoren. Mitteil Dtsch Ges Chirurg 3

    Google Scholar 

  38. Witte J, Goretzki PE, Röher HD (1997) Chirurgie der differenzierten Schilddrüsenkarzinome. Onkologe 3:22–27

    Article  Google Scholar 

  39. Gimm O, Dralle H (1997) Diagnostik und Therapie sporadischer und familiärer medullärer Schilddrüsenkarzinome. Onkologe 3:32–37

    Article  Google Scholar 

  40. Tisell LE, Hansson G, Jansson S (1989) Surgical treatment of medullary carcinoma of the thyroid. Horm Metab Res Suppl 21:29–31

    PubMed  CAS  Google Scholar 

  41. Moley JF, Wells SA, Dilley WG, Tisell LE (1994) Reoperation for recurrent or persistent medullary thyroid cancer. Surgery 114:1090–1095

    Google Scholar 

  42. Scheumann GFW, Seeliger H, Pichlmayr R, Wegener G (1997) Chirurgische Therapieoptionen bei anaplastischen Schilddrüsenkarzinomen. Onkologe 3:43–47

    Article  Google Scholar 

  43. Deutsche Gesellschaft für Nuklearmedizin (1997) Leitlinie zur Radioiodtherapie bei differenzierten (papillären, follikulären) Schilddrüsenkarzinomen. AWMF Online 1997

    Google Scholar 

  44. Farahati J, Reiners C (1997) Postoperative Radioiodtherapie bei differenzierten Schilddrüsenkarzinomen. Onkologe 3:28–31

    Article  Google Scholar 

  45. Rösler H, Birrer A, Lüscher D, Kindser J (1992) Langzeitverläufe beim differenzierten Schilddrüsenkarzinom. Schweiz Med Wschr 122:1843–1857

    PubMed  Google Scholar 

  46. Sautter-Bihl ML (1997) Hat die perkutane Strahlentherapie einen Stellenwert in der Behandlung des Schilddrüsenkarzinoms? Onkologe 3:48–54

    Article  Google Scholar 

  47. Farahati J, Reiners C, Stuschke M, Müller SP, Stüben G, Sauerwein W, Sack H (1996) Differentiated thyroid cancer — Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer 77:172–180

    Article  PubMed  CAS  Google Scholar 

  48. Leisner B, Degelmann G, Dirr W, Kanitz W, Büll U, Langhammer W, Lissner J, Pabst HW (1982) Behandlungsergebnisse bei Sturma maligna 1960–1980. DMW 107:1702–1707

    Article  CAS  Google Scholar 

  49. Müller-Gärtner HW, Brazac HT, Rehpenning W (1991) Prognostic indices for tumor relapse and tumor mortality in follicular thyroid carcinoma. Cancer 67: 1903–1911

    Article  Google Scholar 

  50. Simpson WJ, Panzarella T, Carruthers JS, Gospodarowicz MK, Sutcliffe SB (1988) Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys 14:1063–1075

    Article  PubMed  CAS  Google Scholar 

  51. Philips P, Hanzen C, Andry G, Van Houtte, Frülling J (1993) Postoperative irradiation for thyroid cancer. Eur J Surg Oncol 19:399–404

    Google Scholar 

  52. Tubiana M, Hadda E, Schlumberger M, Hill C, Rougier P, Sarrazin D (1985) External radiotherapy in thyroid cancers. Cancer 55:2062–2071

    Article  PubMed  CAS  Google Scholar 

  53. Jensen MH, Davis RK, Derrick L (1990) Thyroid cancer: a computer-assisted review of 5287 cases. Otolaryngol Head Neck Surg 102:51–65

    PubMed  CAS  Google Scholar 

  54. Rougier P, Parmentier C, Laplanche A (1983) Medullary thyroid carcinoma: prognostic factors and treatment. Int J Radiat Oncol Biol Phys 9:161–169

    Article  PubMed  CAS  Google Scholar 

  55. Scheumann GFW, Wegener G, Dralle H (1990) Radikale chirurgische Intervention mit konventioneller Radiatio versus multimodalem Therapieschema beim undifferenzierten Schilddrüsenkarzinom. Wien Klin Wochenschrift 102:271–273

    CAS  Google Scholar 

  56. Levendag PC, De Porre PM, van Putten WLJ (1993) Anaplastic carcinoma of the thyroid gland treated by radiation therapy. Int J Radiat Oncol Biol Phys 26:125–128

    Article  PubMed  CAS  Google Scholar 

  57. Junor EJ, Paul J, Reed NS (1992) Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy. Eur J Surg Oncol 18:83–88

    PubMed  CAS  Google Scholar 

  58. Kim JH, Leeper RD (1987) Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy. Int J Radiat Oncol Biol Phys 26: 125–128

    Google Scholar 

  59. Sauerwein W, Reiners C, Lederbogen S (1996) Kombinierte Strahlen-Chemotherapie beim anaplastischen Schilddrüsenkarzinom. In: Usadel KH, Weinheimer B (Hrsg) Schilddrüse 1995. Walter de Gruyter Verlag Berlin — New York 1996, p 401–408

    Google Scholar 

  60. Tennvall J, Tallroth E, El Hassan A (1990) Anaplastic thyroid carcinoma. Acta Oncol 29:1025–1028

    Article  PubMed  CAS  Google Scholar 

  61. Glick JH, Kim K, Earle J, O’Connell MJ (1995) An ECOG randomized Phase III trial of CHOP vs. CHOP + radiotherapy for intermediate grade early stage non-Hodgkin’s lymphoma. Proc ASCO 14:391

    Google Scholar 

  62. Miller TP, Dahlberg S, Cassady JR, Carlin S, Chase E, Fisher RI (1996) Three cycles of CHOP plus radiotherapy is superior to eight cycles of CHOP alone for localized intermediate and high grade non-Hodgkin’s lymphoma. A Southwest Oncology Group study. Proc ASCO 15:411

    Google Scholar 

  63. Doria R, Jekel JF, Cooper DL (1993) Thyroid Lymphoma. Cancer 73:200–206

    Article  Google Scholar 

  64. Pujol P, Daures JP, Nsakala N, Baldet L, Bringer J, Jaffiol C (1996) Degree of Thyrotropin Suppression as a Prognostic Determinant in Differentiated Thyroid Cancer. J Clin Endocrinol Metab 81:4318–4323

    Article  PubMed  CAS  Google Scholar 

  65. Keil I, Hesse J, Höffken K (1997) Nachsorge von malignen Schilddrüsentumoren nach abgeschlossener Primärtherapie. Onkologe 3:59–63

    Article  Google Scholar 

  66. Benker G, Sauerwein W, Reiners C, Olbricht Th, Reinwein D (1990) Die Struma maligna: Möglichkeiten der Chemotherapie. In: Diagnostische und operative Strategien bei endokrinen Erkrankungen (Hrsg) Junginger Th, Beyer J, pmi-Verlag, Frankfurt a.M.p 270–275

    Google Scholar 

  67. Raue F (1997) Chemotherapie bei Schilddrüsenkarzinomen: Indikation und Ergebnisse. Onkologe 3:55–58

    Article  Google Scholar 

  68. Schlumberger M, Parmentier C, Delisle MJ, Couette JE, Droz JP, Sarrazin D (1991) Combination therapy for anaplastic giant cell thyroid carcinoma. Cancer 67: 564–566

    Article  PubMed  CAS  Google Scholar 

  69. Simon D, Köhrle J, Schmutzler C, Mainz K, Reiners C, Röher HD (1996) Redifferentiation therapy of differentiated thyroid carcinoma with retinoic acid: basics and first clinical results. Exp Clin Endocrinol Diabetes 104, Suppl 4:13–15

    Google Scholar 

  70. Berding G, Hüfner M, Georgi P (1992) Thyreoglobulin 131J-Ganzkörperszintigraphie und Risikofaktoren in der Nachsorge des differenzierten Schilddrüsenkarzinoms. Nuklearmedizin 31:32–37

    PubMed  CAS  Google Scholar 

  71. Cavalieri RR (1996) Nuclear Imaging in the Management of Thyroid Carcinoma. Thyroid 6:485–492

    Article  PubMed  CAS  Google Scholar 

  72. van Heerden JA, Grant CS, Gharib H, Hay ID, Ilstrup DM (1990) Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 212:395–400

    Article  PubMed  Google Scholar 

  73. Raue F, Frank-Raue K, Winter J (1990) Klinik, Diagnostik und Nachsorge des C-Zellkarzinoms. In: Diagnostische und operative Strategien bei endokrinen Erkrankungen (Hrsg) Junginger Th, Beyer J, pmi-Verlag, Frankfurt a.M. p 276–282

    Google Scholar 

  74. Briele B, Hotze A, Kropp J, Bockisch A, Overbeck B, Grünwald F, Kaiser W, Biersack HJ (1991) Vergleich von 201T1 und 99mTc-MIBI in der Nachsorge des differenzierten Schilddrüsenkarzinoms. Nuklearmedizin 30:115–124

    PubMed  CAS  Google Scholar 

  75. Ramanna L, Waxman A, Braunstein G (1991) Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations. J Nucl Med 32:441–446

    PubMed  CAS  Google Scholar 

  76. Grünwald F, Schomburg A, Bender H, Klemm E, Menzel C, Bultmann T, Palmedo H, Ruhlmann J, Kozak B, Biersack HJ (1996) Flourine-18 flourodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 23:312–319

    Article  PubMed  Google Scholar 

  77. Reiners C, Müller StP (1993) Bildgebende Verfahren beim C-Zellkarzinom der Schilddrüse. In: Beyer J, Junginger Th, Lehnert K, Walgenbach S (Hrsg) Diagnostische und chirurgische Aspekte bei endokrinen Erkrankungen. SympoMed Verlag, München.p 213–217

    Google Scholar 

  78. Ladenson PW, Braverman LE, Mazzaferri EL, Brucker-Davis F, Cooper DS, Garber JR, Wondisford FE, Davies TF, DeGroot LJ, Daniels GH, Ross DS, Weintraub BD (1997) Comparison of Administration of Recombinant Human Thyrotropin with Withdrawal of Thyroid Hormone for Radioactive Iodine Scanning in Patients with Thyoid Carcinoma. N Engl J Med 337:888–896

    Article  PubMed  CAS  Google Scholar 

  79. Gottlieb JA, Stratton Hill C (1975) Adriamycin (NSC 123 127) therapy in thyroid carcinoma. Cancer Chemother Rep 6:283–296

    Google Scholar 

  80. Burgess MH, Stratton Hill C (1978) Chemotherapy in the management of thyroid cancer. In. Thyroid cancer (Hrsg) Greenfield L. D. Palm Beach, Florida. CRC Press, p 33

    Google Scholar 

  81. Shimaoka K, Schoenfeld DA, Dewys WD, Creech RH, DeConti R (1985) A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma. Cancer 56:2155–2160

    Article  PubMed  CAS  Google Scholar 

  82. Scherübl H, Raue F, Ziegler R (1990) Combination chemotherapy of advanced medullary and differentiated thyroid cancer. Phase II study. J Cancer Res Clin Oncol 116:21–23

    Article  PubMed  Google Scholar 

  83. Tennvall J, Tallroth E, el Hassan A, Lundell G, Akerman M, Biorklund A, Blomgren H, Lowhagen T, Wallin G (1990) Anaplastic thyroid carcinoma. Doxorubicin, hyperfractionated radiotherapy and surgery. Acta Oncol 29:1025–1028

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. C. Reiners
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Stuschke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Innere Klinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum Essen, Universitätsklinikum Essen, Hufelandstraße 55, 45122, Essen, Deutschland

    Siegfried Seeber  & Jochen Schütte  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Reiners, C., Stuschke, M. (1998). Schilddrüsenkarzinome. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10493-4_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10493-4_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-63821-6

  • Online ISBN: 978-3-662-10493-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation